Cat. No. |
Product Name |
Information |
PC-61941 |
Glecaprevir
|
Glecaprevir (ABT 493. |
PC-61888 |
Filibuvir
|
Filibuvir (PF-00868554. |
PC-61873 |
Ravidasvir dihydrochloride
|
Ravidasvir (PPI-668. |
PC-61872 |
Ravidasvir
|
Ravidasvir (PPI-668. |
PC-61524 |
Samatasvir
|
Samatasvir (IDX719) is a highly potent, selective inhibitor of HCV NS5A that effectively inhibits HCV genotype 1-5 replicons with EC50 of 2-24 pM. |
PC-61523 |
TD-6450
|
TD-6450 is a next generation, potent HCV NS5A inhibitor that has potent antiviral activity against HCV infection.. |
PC-60953 |
Faldaprevir
|
A potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively. |
PC-60429 |
MK-8876
|
A novel, broadly acting non-nucleoside inhibitor of HCV NS5B polymerase with IC50 of 3 nM and 2 nM for GT1b and GT2a, respectively. |
PC-60427 |
BMS-929075
|
A highly potent, selective, orally bioavailable HCV NS5B polymerase inhibitor with IC50 of 9, 4, and 18 nM for GT1a, GT1b, and GT1b-C316N mutant in HCV replicon assay, respectively. |
PC-60425 |
GSK-625433
|
A highly potent, selective HCV NS5B polymerase inhibitor for treatment of HCV infection.. |
PC-60424 |
BMT-052
|
A second generation, orally biovailable pan-genotypic HCV NS5B polymerase inhibitor with EC50 of 1-10 nM. |
PC-42588 |
Balapiravir
|
The prodrug of R1479, a potent, specific and oral HCV NS5B polymerase inhibitor. |